Drug Trial Radar · NCT06182085
Study to Assess Safety and Efficacy of PRI-002 in Patients With MCI to Mild Dementia Due to Alzheimer's Disease (AD)
Last checked: Nov 19, 2026Latest source record: Jul 10, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
304
Actual
Start
Feb 15, 2024
Primary completion
Apr 15, 2026
Study completion Jul 2, 2026
Sponsor
- Lead sponsor
- PRInnovation GmbHIndustry
- Sponsor type
- Industry
- Collaborators
- Priavoid; Federal Agency for Disruptive Innovation - SPRIN-D; Julius Clinical
- First posted
- Dec 26, 2023
Design
- Study type
- Interventional
- Phase
- Phase 2
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Quadruple (participant, care provider, investigator, outcomes assessor)
- Primary purpose
- Treatment
- FDA-regulated drug
- No
- Who can join
- All sexes, from 55 years, up to 80 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
Alzheimer's disease (AD) is the most common form of dementia. In the brains of people with AD, certain small substances stick together. This leads to changes in thinking and behaviour. The company PRInnovation is developing a new treatment for Alzheimer's disease, called PRI-002. It is thought that PRI-002 can cut the sticked substances back into small pieces. That would reduce the effects of Alzheimer's disease. In the current study the investigators examine whether PRI-002 is safe and effective in participants with mild cognitive impairment (MCI) or mild dementia due to AD.
Conditions
- Mild Cognitive Impairment Due to Alzheimer's Disease
- Alzheimer's Disease, Early Onset
Interventions
PRI-002Drug
Oral administration
PlaceboDrug
Oral administration
Primary outcomes
What the sponsor says the trial is designed to measure.
- To evaluate the safety and tolerability of multiple doses of PRI-002 in subjects with MCI or mild dementia due to AD, based on incidence of drug-related adverse events (AEs).Time frame: Baseline to week 48.
- To evaluate the efficacy of multiple doses of PRI-002 in subjects with MCI or mild dementia due to AD, based on the Clinical Dementia Rating - Sum of Boxes (CDR-SB).Time frame: Baseline to week 48.
Locations
38 sites in 6 countries. Site status is shown where the registry gives one.
Neuro Health Centrum ltd.
Brno, Czechia
NeuropsychiatrieHK, s.r.o.
Hradec Králové, Czechia
A-Shine, s.r.o.
Pilsen, Czechia
CLINTRIAL, s.r.o.
Prague, Czechia
FORBELI s.r.o.
Prague, Czechia
Neuropsychiatrie s.r.o.
Prague, Czechia
INEP Medical s.r.o.
Prague, Czechia
Uniklinik RWTH Aachen
Aachen, Germany
Charité - Universitätsmedizin
Berlin, Germany
Universitätsklinikum Düsseldorf
Düsseldorf, Germany
Universitätsklinikum Magdeburg
Magdeburg, Germany
ISPG - Institut für Studien zur Psychischen Gesundheit
Mannheim, Germany
Technische Universität München
München, Germany
Universitätsklinikum Münster - Klinik für Allgemeine Neurologie
Münster, Germany
University Medical Center Rostock
Rostock, Germany
Universitätsklinikum Ulm
Ulm, Germany
Ospedale Bellaria - IRCCS Istituto delle Scienze Neurologiche
Bologna, Italy
ASST Spedali Civili di Brescia
Brescia, Italy
Clinica Neurologica Dipartimento di Neuroscienze e Imaging (CAST)
Chieti, Italy
IRCCS Ospedale San Raffaele
Milan, Italy
Fondazione IRCCS.Istituto Neurologico Carlo Besta
Milan, Italy
Ospedale Santa Maria della Misericordia
Perugia, Italy
AOU Policlinico Umberto I
Rome, Italy
Fondazione Policlinico Universitario A. Gemelli IRCCS
Rome, Italy
Brain Research Center Den Bosch B.V.
's-Hertogenbosch, Netherlands
Brain Research Center Amsterdam B.V.
Amsterdam, Netherlands
Brain Research Center Zwolle B.V.
Zwolle, Netherlands
Revit Sp. z o.o., Podlaskie Centrum Psychogeriatrii
Bialystok, Poland
Krakowska Akademia Neurologii Sp. z o.o., Centrum Neurologii Klinicznej
Krakow, Poland
NeuroCor, ul. Medweciego 7/U12
Krakow, Poland
Euromedis Sp. z o.o., Centrum Medyczne EUROMEDIS
Szczecin, Poland
Neuroprotect Sp. z o.o., Centrum Medyczne NeuroProtect
Warsaw, Poland
Wielospecjalistyczne Centrum Medyczne "Ibismed" s.c.
Zabrze, Poland
Fundació ACE - Institut Català de Neurociències Aplicades
Barcelona, Spain
Hospital Universitario Virgen Macarena,
Seville, Spain
Hospital Universitario Doctor Peset
Valencia, Spain
Hospital Viamed Montecanal
Zaragoza, Spain
Hospital Clínico Universitario Virgen de la Arrixaca
El Palmar, Murcia, Spain
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.